We report the first Italian case of Nijmegen breakage syndrome (NBS). The proband is an immunodeficient, microcephalic, 11 year old boy with a "birdlike" face. He developed a T cell rich B cell lymphoma. Spontaneous chromosomal instability was detected in T and B lymphocytes and fibroblasts; chromosomes 7 and 14 were only sporadically involved in the rearrangements and no clonal abnormality was present.
The Nijmegen breakage syndrome (NBS) is a rare, recessive disorder, clinically and genetically heterogeneous, characterised by microcephaly, bird-like face, short stature, immunodeficiency, and chromosome instability.-The chromosomal aberrations in NBS patients are similar to those seen in ataxia telangiectasia (AT), preferentially involving chromosomes 7 and 14. Other features in common with AT patients are increased risk of cancer, hypersensitivity to ionising radiation, and radioresistant DNA synthesis. NBS We report here on an 11 year old boy representing the first Italian case of NBS. His clinical features, his sensitivity to x rays and to the radiomimetic drug bleomycin, and the absence of inhibition of DNA synthesis after bleomycin exposure are typical of the syndrome, but the pattern of the chromosomal anomalies detected is different.
Case report
The patient is a boy, the second child of non-consanguineous Italian parents, whose ancestors originated from the same location in northern Italy. Predisposition towards malignancy was analysed in both parents' families. In the mother's family, among 65 subjects over four generations, one died from a pancreatic carcinoma and two, affected by silicosis, developed lung cancer. In the father's family, among 107 subjects over four generations, two aunts died from breast cancer. The pregnancy was uneventful until the 20th week, when growth retardation was diagnosed by ultrasound examination. Investigations for TORCH infections were negative. The boy was born at term in September 1985. At birth the patient weighed 2550 g (3rd centile), was 43 cm long (<3rd centile), and his head circumference was 31.8 cm (<3rd centile). He experienced recurrent upper and lower respiratory infections starting before he was 1 year of age.
When the child was 6 years old (fig 1) , he was admitted for the first time to the Department of Paediatrics of the University of Pavia for further investigations on account of his recurrent respiratory infections.
On admission his weight was 15.6 kg (<3rd centile), height 107.5 cm (between the 3rd and 10th centiles), and head circumference 45 cm (<3rd centile). Bone age was 4 years according to Greulich The effect of bleomycin (dose range 0.1-50 gg/ml) on DNA synthesis in fibroblasts was measured by liquid scintillation technique and by autoradiography, as previously described.6 7 Briefly, after one hour of bleomycin treatment, cells were rinsed twice with warm medium, incubated at 37°C in medium containing 3H-thymidine ('H-TdR, New England Nuclear, specific activity 20 Ci/mmol) at a final concentration of 10 jiCi/ml, and processed four hours later. The amount of 3H-TdR incorporated by cells was determined by measuring the acid precipitable radioactivity as previously described.6 Within a single experiment, each point was the mean of at least two separate samples and was expressed as a percentage of the mean value obtained from at least three untreated control samples.
For autoradiography, following a four hour incubation with 3H-TdR, cells were rinsed with phosphate buffered saline (PBS) and fixed with methanol-acetic acid 3:1. Slides were processed using Ilford K2 emulsion, developed after five or 24 hours at 4°C, and stained with May-Grunwald and Giemsa solutions. The grains over 40 S phase nuclei were counted in five hour exposed preparations; the number of heavily labelled nuclei, that is, S phase cells, was evaluated by scoring at least 500 nuclei in 24 hour exposed preparations.
CELL CYCLE ANALYSIS
Parallel cultures of proliferating fibroblasts were incubated, 48 hours after seeding, in fig 2) . In PHA stimulated In order to investigate the effect of bleomycin exposure on DNA synthesis, proliferating fibroblasts were treated for one hour with different doses of bleomycin, labelled with 'H-TdR for four hours, harvested, and processed for scintillation counting or for autoradiography. As shown in fig 4, the total amount of 'H-TdR incorporated by normal C3PV fibroblasts was already reduced to 71 % of the control level after 0.1 gg/ml bleomycin, and dropped to 23% after 50 ,ug/ml bleomycin. The corresponding levels in AT396 fibroblasts were 99% and 62%, confirming that the inhibition of DNA synthesis following bleomycin exposure was less pronounced in AT cells than in normal cells.'2 As in AT fibroblasts, in the patient's fibroblasts the exposure to bleomycin appeared to depress the rate of DNA replication to a significantly lesser extent than in normal cells. The degree of reduction, however, was more drastic than in AT cells, ranging between 90% and 47% of the control level after exposure to 0.1 and 50 jg/ml bleomycin, respectively.
On autoradiographic preparations, the effect of one hour's bleomycin treatment (0.1, 1, 10 gg/ml) was investigated by analysing two different parameters: the percentage of cells in S phase (fig 5) and the mean number of grains in S phase nuclei (table 4). The percentage of cells in S phase in strain C3PV was progressively reduced following exposure to increasing doses of the radiomimetic agent, whereas no significant differences were observed in the AT396 strain. An intermediate response was present in the proband's cells.
The evaluation of the mean number of autoradiographic grains in S phase nuclei (table 4) indicated that treatment with 10 gg/ml bleomycin had a drastic effect on the rate of DNA synthesis in C3PV cells, whereas no differences were observed in AT and in patient cells.
The effect of bleomycin exposure on cell cycle was further investigated by flow cytometry. The distribution of cells in the cycle was determined in fibroblast cultures treated for one hour with 10 gg/ml bleomycin and incubated in normal medium during the following four, 12, and 24 hours (fig 6) . The analysis showed that C3PV cells underwent a growth arrest in the GI phase, already significant at 12 hours after incubation. As expected, the AT396 cell strain did not show any significant accumulation of cells in each phase of the cell cycle after drug exposure. The patient's cells showed, in response to bleomycin treatment, an intermediate behaviour between normal and AT396 cells. In fact, although a progressive reduction in the number of cells in S phase was observed during the incubation period following treatment, this effect did not occur to the extent observed in normal cells. The percentage of S phase cells 24 hours after treatment was reduced to 67% and 31% of the values in the corresponding untreated samples in the patient and C3PV cells, respectively.
Discussion
Our patient has the cardinal features of NBS: microcephaly with bird-like face, short stature, immunodeficiency, AFP at normal levels, spontaneous chromosome instability, increased sensitivity to ionising radiation and bleomycin, radioresistant DNA synthesis, and predisposition to malignancies. He showed a derangement of both humoral and cell mediated immunity which predisposed him to severe infections. In particular, despite Incubation time (hours) Figure 6 Effect of exposure to 10,uglml bleomycin on cell cycle progression byflow cytometric analysis in fibroblasts from the normal strain C3PV the AT cell strain AT396, and the proband's cell strain 1548. The percentage of cells in Gl (hatched columns), S (black columns), and G2 (white columns) phases in untreated samples (0) and in drug treated samples analysed by flow cytometry afterfour, 12, and 24 hours of recovery in normal medium is shown.
In published reports, no rearrangements have been reported in NBS fibroblasts. Only chromosome and chromatid breaks were present in all the patients, apart from the case described by Conley et al,3 assigned NBS V2, in which 33% of the cells had rearrangements. Chromosome rearrangements, however, have been described in AT fibroblasts, although different from those seen in lymphocytes."4 In our patient's fibroblasts chromosome translocations, isochromosomes, partial endoreduplications, aneuploidies, and supernumerary marker chromosomes were also observed.
From a cytogenetic point of view, our patient's condition is similar to that described in a girl with a chromosome instability disorder sharing features with NBS. '5 In that case the characteristic abnormalities of chromosomes 7 and 14 were present together with rearrangements involving other chromosomes. Dicentric and tricentric chromosomes were observed both in lymphocytes and fibroblasts. That patient, however, differed from NBS subjects as she did not suffer from immunodeficiency and was not hypersensitive to the radiomimetic drug bleomycin. In contrast, our patient appeared to be sensitive both to bleomycin and to ionising radiation, although not to the same extent as AT reference cells.
Inhibition of DNA synthesis in our patient's fibroblasts exposed to bleomycin was also abnormal, being less pronounced than in cells from a normal donor, in agreement with published data." 16 Nevertheless, the extent of inhibition was higher than that observed in AT reference cells. This may be because, in the 1548 strain, bleomycin seems partially to affect the entry of cells into S phase, whereas in AT it does not interfere drastically with either the rate of DNA synthesis or the progression from Gl to S phase as it does in normal cells.
Cell cycle analysis has shown that, in our experimental conditions, bleomycin induces in normal cells a drastic reduction in the percentage of S phase cells and Gl arrest. These effects were not seen in AT cells which are defective in G1, S, and G2 cell cycle check points,'7 as also indicated by the evidence that both the rate of DNA synthesis and entry into S phase were unaffected (figs 4 and 5). Following x rays or bleomycin treatment, an accumulation of cells in the G2 phase has also been described in AT cells. 18 19 However, this effect is dependent on the experimental conditions (that is, cell type, synchronisation and culture time, dose), as also pointed out by Antoccia et al,'0 and therefore is not evident from our analysis, performed by means of the same protocol applied to evaluate the inhibition of DNA synthesis.
In the patient described here, cell cycle progression after exposure to bleomycin was similar to AT cells, although in the former a progressive reduction in the percentage of S phase cells was found. The results described by Barbi et afl on PHA stimulated lymphocytes of NBS patients, showed an accumulation in G2 phase after exposure to x rays. This behaviour may be explained again by the different experimental conditions used. However, further investigations are needed to clarify whether the pattern of response to bleomycin, similar to that in AT but less pronounced, is peculiar to the patient described in this paper or whether it is a general feature of NBS. In AT patients "in vitro" intermediate radiosensitivity to ionising radiation and bleomycin is rare, but not exceptional.
On clinical evaluation our patient shares features with NBS subjects, but cytogenetic and cell biological data do not completely overlap. However, great variability has been described among NBS patients. Immunodeficiency is a peculiar feature of NBS, but it was not present in the child described by Barbi et 
